Skip to main content
. Author manuscript; available in PMC: 2019 Mar 1.
Published in final edited form as: Cancer Prev Res (Phila). 2017 Nov 20;11(3):157–164. doi: 10.1158/1940-6207.CAPR-17-0278

Fig. 4.

Fig. 4

Percentage survival of B6C3F1 mice treated by topical application of DB[a,l]PDE at 3nmol three times a week for 38 weeks during the progress of the bioassay.